Abstract:As an integral aspect of the metabolic reprogramming that occurs in cancer, oncogenic KRAS mutations drive the stimulation of macropinocytosis, a type of endocytosis that mediates nonselective fluid-phase uptake. Using KRAS-driven models of pancreatic ductal adenocarcinoma (PDAC), we were the first to demonstrate that macropinocytosis functions in tumor cells as a nutrient acquisition pathway. Macropinocytosis triggers the internalization of extracellular proteins via discrete endocytic vesicles called macropinosomes. The incoming protein cargo is targeted for lysosome-dependent degradation, causing the intracellular release of amino acids. These protein-derived amino acids support metabolic fitness by contributing to the intracellular amino acid pools, as well as to the biosynthesis of central carbon metabolites. In this way, macropinocytosis represents a novel amino acid supply route that tumor cells use to survive the nutrient-poor conditions of the tumor microenvironment. While the tenets of the signal transduction events that drive macropinocytosis in cancer have emerged, a detailed picture of the macropinosome itself is not yet available. With the aid of nanotechnology, we have developed a methodology to isolate a pure fraction of macropinosomes from PDAC cells. Using a large-scale proteomic approach, we have been able to generate a list of proteins that reside in macropinosomes. The specificity of this approach was confirmed through the identification and validation of proteins known to specifically localize to these organelles in different contexts, such as Rab5 or SDC1. Thanks to this innovative method, we have demonstrated the involvement of two calcium channels, ATP2B1 and ATP2B4, in the formation of macropinosomes. By elucidating the molecular anatomy of KRAS-driven macropinosomes, we will gain further insight into the regulation and function of macropinocytosis in cancer. Moreover, having a clearer picture of the macropinosome will make us better positioned to exploit this pathway therapeutically and deliver breakthroughs to patients. Citation Format: Ambroise Manceau, Koen M. Galenkamp, Cheska M. Galapate, Cosimo Commisso. The macropinosome: Uncovering the molecular anatomy of an oncogene-driven organelle [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4452.

Cellular Regulation of Macropinocytosis

The Role and Therapeutic Potential of Macropinocytosis in Cancer

Macropinocytosis: an endocytic pathway for internalising large gulps

The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets

Macropinocytosis in Different Cell Types: Similarities and Differences

Regulation of cancer metabolism by O-GlcNAcylation

Growing Macrophages Regulate High Rates of Solute Flux by Pinocytosis

Targeted drug delivery system inspired by macropinocytosis

Revealing macropinocytosis using nanoparticles

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

Abstract B088: The macropinosome: Uncovering the molecular anatomy of an oncogene-driven organelle

Abstract 4452: The macropinosome: Uncovering the molecular anatomy of an oncogene-driven organelle

Functional significance of ion channels during macropinosome resolution in immune cells

Regulation of autophagy in tumor cells and application of targeting autophagy in cancer

A Novel Method to Image Macropinocytosis in Vivo

Eyeing autophagy and macropinocytosis in the corneal/limbal epithelia

Cell polarity proteins promote macropinocytosis in response to metabolic stress

Abstract PR-19: Cell polarity proteins as novel regulators of macropinocytosis

Function and regulation of Rab GTPases in cancers

Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention

Differential signaling during macropinocytosis in response to M-CSF and PMA in macrophages